Zahraa AlHilli, MD, MBA

Appointed
2016

Education & Fellowships

Graduate School - University of Chicago Booth School of Business
Chicago, IL
2023

Fellowship - Mayo Clinic
Endocrine Surgery
Rochester, MN
2016

Fellowship - Mayo Clinic
Breast Surgical Oncology
Rochester, MN
2015

Residency - Royal College of Surgeons Ireland
General Surgery
Dublin, Ireland
2014

Graduate School - Royal College of Surgeons Ireland
Dublin, Ireland
2009

Graduate School - Queens University of Belfast Faculty of Medicine
Masters in Medical Education
Belfast, United Kingdom
2009

Medical Education - Royal College of Surgeons Ireland
MB/BCh/BAO/LRCPSI
Dublin, Ireland
2004

Certifications

• Surgery - General Surgery

Specialty Interests

breast cancer, breast disease, oncoplastic breast surgery, nipple sparing mastectomy

Awards & Honors

•  2015 Balfour Surgical Research Award, Mayo Clinic
•  2015 Colles Travelling Fellowship in Surgery, Royal College of Surgeons in Ireland
•  2014 Joint American College of Surgeons/ Royal College of Surgeons in Ireland Resident Exchange Award
•  2014 Ethicon Foundation Travel Grant, Royal College of Surgeons in Ireland
•  2009 Sheppard Research Prize, Royal College of Surgeons in Ireland and Beaumont Hospital, Dublin, Ireland
•  2008 William O'Keefe Research Prize, Ireland
•  2003 John McAuliffe Gold Medal and First Place in Otolaryngology, Royal College of Surgeons in Ireland

  
  

See publications for Zahraa AlHilli, MD, MBA.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/26/2024, Dr. AlHilli has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.